-
BOW015 (infliximab) - Pipeline - Epirus Biopharmaceuticals
Our lead program, BOW015 (infliximab, reference biologic Remicade
®) is a monoclonal antibody against tumor necrosis factor alpha (TNF-α). It is used to treat autoimmune diseases, including rheumatoid...
-
Home - Epirus News
Acne can have multiple causes; it could be because of your diet, skin care, genetics,and hormones. Apart from these, studies show that acne is a reflection of something that is happening inside your b...
-
Home - Epirus News
Home
Acne can have multiple causes; it could be because of your diet, skin care, genetics,and hormones. Apart from these, studies show that acne is a reflection of something that is happening inside y...
-
Home - Epirus News
The rise of thyroid supplements is nothing new, but it has recently been getting a ton of attention from consumers and consumer watch agencies lately. Since thyroid issues are pretty common to most pe...
-
Management - About Epirus - Epirus Biopharmaceuticals
Chief Executive Officer
Scott joined EPIRUS as chief executive officer in 2016 and is currently a managing Partner at 5AM Ventures. Dr. Rocklage has over three decades of healthcare management experie...
-
Overview - Pipeline - Epirus Biopharmaceuticals
EPIRUS Biopharmaceuticals seeks to build a sustainable platform through a therapeutically-focused pipeline of monoclonal antibodies targeting rare diseases. Our current pipeline focuses on biosimil...